These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 24890789)

  • 1. Tenofovir disoproxil fumarate rescue therapy for HBV recurrence in two liver transplant recipients with previous multiple nucleo(s/t)ide treatment failures.
    Rao W; Xie M; Shen Z
    Transpl Int; 2014 Oct; 27(10):e102-4. PubMed ID: 24890789
    [No Abstract]   [Full Text] [Related]  

  • 2. New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.
    Cholongitas E; Goulis I; Antoniadis N; Fouzas I; Imvrios G; Papanikolaou V; Akriviadis E
    Transpl Int; 2014 Oct; 27(10):1022-8. PubMed ID: 24909714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade.
    Neff GW; O'brien CB; Nery J; Shire N; Montalbano M; Ruiz P; Nery C; Safdar K; De Medina M; Tzakis AG; Schiff ER; Madariaga J
    Liver Transpl; 2004 Nov; 10(11):1372-8. PubMed ID: 15497163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.
    McGonigal KH; Bajjoka IE; Abouljoud MS
    Pharmacotherapy; 2013 Sep; 33(9):e170-6. PubMed ID: 23744810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.
    Wesdorp DJ; Knoester M; Braat AE; Coenraad MJ; Vossen AC; Claas EC; van Hoek B
    J Clin Virol; 2013 Sep; 58(1):67-73. PubMed ID: 23880162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation.
    Stravitz RT; Shiffman ML; Kimmel M; Puri P; Luketic VA; Sterling RK; Sanyal AJ; Cotterell AH; Posner MP; Fisher RA
    Liver Int; 2012 Aug; 32(7):1138-45. PubMed ID: 22348467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
    Chang MS; Olsen SK; Pichardo EM; Stiles JB; Rosenthal-Cogan L; Brubaker WD; Guarrera JV; Emond JC; Brown RS
    Transplantation; 2013 Apr; 95(7):960-5. PubMed ID: 23545507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant.
    Wai CT; Prabhakaran K; Wee A; Lee YM; Dan YY; Sutedja DS; Mak K; Isaac J; Lee KH; Lee HL; Da Costa M; Lim SG
    Transplant Proc; 2004 Oct; 36(8):2313-4. PubMed ID: 15561234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation for severe hepatic trauma.
    Plackett TP; Barmparas G; Inaba K; Demetriades D
    J Trauma; 2011 Dec; 71(6):1880-4. PubMed ID: 22182899
    [No Abstract]   [Full Text] [Related]  

  • 10. HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence.
    Karasu Z; Ozacar T; Akarca U; Ersoz G; Erensoy S; Gunsar F; Kobat A; Tokat Y; Batur Y
    J Viral Hepat; 2005 Mar; 12(2):212-5. PubMed ID: 15720538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favourable outcome of adefovir-dipivoxil treatment in acute de novo hepatitis B after liver transplantation.
    Toniutto P; Fumo E; Caldato M; Apollonio L; Perin A; Pirisi M
    Transplantation; 2004 Feb; 77(3):472-3. PubMed ID: 14966431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine.
    Günther M; Neuhaus R; Bauer T; Jilg W; Holtz JA; Bienzle U
    Liver Transpl; 2006 Feb; 12(2):316-9. PubMed ID: 16447191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and adefovir therapy.
    Zhang FK; Zhang Y; Zhang JY; Jia JD; Wang BE
    Transpl Infect Dis; 2009 Dec; 11(6):549-52. PubMed ID: 19725909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco use by liver transplant recipients: grappling with a smoking gun.
    Muñoz SJ
    Liver Transpl; 2005 Jun; 11(6):606-9. PubMed ID: 15915485
    [No Abstract]   [Full Text] [Related]  

  • 15. Adefovir dipivoxil therapy in liver transplant recipients with lamivudine-resistant hepatitis B virus.
    Herreros de Tejada Echanojáuregui A; Moreno Planas JM; Rubio González E; Portero Azorin F; López Monclús J; Revilla Negro J; Lucena de la Poza JL; Sánchez Turrión V; Barrios Peinado C; Cuervas-Mons Martínez V
    Transplant Proc; 2005 Apr; 37(3):1507-8. PubMed ID: 15866657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular stent placement for interposed middle hepatic vein graft occlusion after living-donor liver transplantation using right-lobe graft.
    Shin JH; Sung KB; Yoon HK; Ko GY; Kim KW; Lee SG; Hwang S; Ahn CS; Kim KH; Moon DB; Song HY; Ha TY
    Liver Transpl; 2006 Feb; 12(2):269-76. PubMed ID: 16447197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coccidioidomycosis in liver transplantation.
    Blair JE
    Liver Transpl; 2006 Jan; 12(1):31-9. PubMed ID: 16382459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis analysis of hepatitis B virus recurrence after liver transplantation: a single-center study of 38 cases].
    Qu W; Sun LY; Zhu ZJ; Deng YL; Sun XY; Rao W; Zhang YM; Zhang JJ; Jiang WT; Gao W; Shen ZY
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):10-3. PubMed ID: 22464698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy.
    Lavocat F; Dény P; Pichoud C; Al Hawajri N; Kitrinos K; Borroto-Esoda K; Zoulim F
    J Hepatol; 2013 Oct; 59(4):684-95. PubMed ID: 23742912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and differentiation of rejection after liver transplantation: report of 5 cases.
    Chen JW; Chen DZ; Yang ZR
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):182-4. PubMed ID: 15908312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.